ALVERON PHARMA CLOSES SERIES A ROUND TO ADVANCE A CYCLODEXTRIN BASED PROCOAGULANT MEDICINE INTO THE CLINIC Alveron Pharma, a newly incorporated company established by Okklo Life Sciences BV and Sanquinnovate (part of Sanquin), is pleased to announce the closing of a EUR 6.5M Series A financing round led by Thuja together with Waterman Ventures and …
Okklo Life Sciences B.V. (Nijmegen, The Netherlands) and SolAeroMed Inc. (Calgary, Canada) have signed an agreement to join forces in the field of cyclodextrins and pulmonary diseases. The collaboration aims to optimize the development of novel cyclodextrins for the treatment of cystic fibrosis. In this partnership SolAeroMed will test proprietary cyclodextrins designed by Okklo for …